Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.68 EUR | -2.74% | +1.43% | -35.01% |
05-07 | Talea Group launches its private label branded Farmaè | AN |
04-23 | Talea closes first quarter with revenues up | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The stock, which is currently worth 2024 to 0.44 times its sales, is clearly overvalued in comparison with peers.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Internet Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-35.01% | 43.04M | - | ||
+2.40% | 193B | C- | ||
-5.92% | 191B | C | ||
-1.09% | 99.27B | B- | ||
+38.58% | 91.5B | B | ||
+7.45% | 85.61B | B | ||
+14.14% | 53.77B | B- | ||
+14.79% | 25.36B | B- | ||
+26.53% | 11.07B | B+ | ||
-11.88% | 8.49B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- FAR Stock
- Ratings Talea Group S.p.A.